Publication: SEOM-TTCC clinical guideline in nasopharynx cancer (2021).
Loading...
Identifiers
Date
2022-03-18
Authors
Rueda Domínguez, Antonio
Cirauqui, Beatriz
García Castaño, Almudena
Alvarez Cabellos, Ruth
Carral Maseda, Alberto
Castelo Fernández, Beatriz
Iglesias Rey, Leticia
Rubió-Casadevall, Jordi
Arrazubi, Virginia
Mesía, Ricard
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
Description
MeSH Terms
Humans
Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms
Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms
DeCS Terms
CIE Terms
Keywords
Clinical Practice Guidelines, Diagnosis, Follow-up, Nasopharyngeal cancer, Treatment